investigators, O. s. (2021). Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).
Chicago Style Citationinvestigators, ORBE study. Real-world Study in Severe Eosinophilic Asthma Patients Refractory to Anti-IL5 Biological Agents Treated With Benralizumab in Spain (ORBE Study). 2021.
MLA Citationinvestigators, ORBE study. Real-world Study in Severe Eosinophilic Asthma Patients Refractory to Anti-IL5 Biological Agents Treated With Benralizumab in Spain (ORBE Study). 2021.
Warning: These citations may not always be 100% accurate.